Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Investigative Dermatology|November 25, 2003
Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptorRaju V S R K Gottumukkala, Elizabeth A Waterman, Laura M Herd, et al.The Journal of Clinical Investigation|April 3, 2002
The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligoE Helen Kemp, Elizabeth A Waterman, Brian E Hawes, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 10, 2006
Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patientsRaju V S R K Gottumukkala, Nikos G Gavalas, Samia Akhtar, et al.Contact Dermatitis|August 8, 2007
Contact sensitivity to preservatives in the UK, 2004-2005: results of multicentre studyCherng T Jong, Barry N Statham, Cathy M Green, et al.Contact Dermatitis|November 3, 2009
The importance of propolis in patch testing--a multicentre surveySanjay Rajpara, Mark S Wilkinson, Claudah M King, et al.Pigment Cell & Melanoma Research|February 18, 2011
Koebner's phenomenon in vitiligo: European position paperNanja van Geel, Reinhart Speeckaert, Alain Taieb, et al.The Journal of Investigative Dermatology|November 19, 2010
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLPStanca A Birlea, Ying Jin, Dorothy C Bennett, et al.The Journal of Investigative Dermatology|February 18, 2011
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onsetYing Jin, Stanca A Birlea, Pamela R Fain, et al.Nature Genetics|June 8, 2010
Common variants in FOXP1 are associated with generalized vitiligoYing Jin, Stanca A Birlea, Pamela R Fain, et al.The New England Journal of Medicine|April 23, 2010
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligoYing Jin, Stanca A Birlea, Pamela R Fain, et al.Pageof 5